Versiti Acquires Cenetron Central Laboratories and Salus IRB
Versiti, has announced the acquisition of Texas-based Cenetron Central Laboratories, and its subsidiary, Salus IRB, offering both organizations the opportunity to expand clinical trial services and expertise.
“By joining forces with an industry leader such as Cenetron, we gain the strength of an organization that specializes in pre-analytical activities that are critical to the success of clinical trials,” said Versiti President and CEO Chris Miskel. “Clinical trials are critical to medical advances that translate to patient care.”
Cenetron will provide Versiti’s diagnostic laboratories with a spectrum of clinical trial solutions from project initiation, kit development and sample logistics, specialized testing, data management, and project management.
The acquisition will not impact Cenetron’s 40 employees, and the laboratory will maintain its name and current location in Austin. Versiti, headquartered in Milwaukee, has 2,000 employees at its locations in Illinois, Indiana, Michigan, Ohio and Wisconsin.
“Versiti and Cenetron are dedicated to a common mission of advancing medical science, and patient care, through clinical trials,” said Cenetron President Dwight DuBois, M.D. “The entire Cenetron organization is both excited and proud to be aligned with an organization with Versiti's sterling reputation."
Dr. DuBois will remain at Cenetron as the laboratory’s medical director.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
